key: cord-0806756-so2qwq92 authors: Fantin, Nick; Taft, Brad; Ugalde, Juan; Spring, Katie; Lam, Hannah; Tran, Alex; Green, Jessica title: Validation of the COVID-19 Indoor Test™ by Phylagen for Detection of SARS-CoV-2 Virus on Stainless Steel Surfaces AOAC Performance Tested Method(SM) 122004 date: 2021-04-02 journal: J AOAC Int DOI: 10.1093/jaoacint/qsab051 sha: bb8013c09483227540f86f2acd73e4a6e2794268 doc_id: 806756 cord_uid: so2qwq92 BACKGROUND: The COVID-19 Indoor Test™ by Phylagen uses a real-time PCR Assay to detect nucleic acid from SARS-CoV-2, the causative agent of COVID-19, which is extracted from swabs sampled from environmental surfaces. This information can be used to detect the presence of the virus in indoor environments. OBJECTIVE: To validate the COVID-19 Indoor Test(TM) by Phylagen as part of the AOAC Research Institute’s Emergency Response Validation Performance Tested Method(SM) program. METHODS: The COVID-19 Indoor Test by Phylagen assay was evaluated for specificity using in silico analysis of 15,764 SARS-CoV-2 sequences and 65 exclusivity organisms. The candidate method was also evaluated in an unpaired matrix study design for one environmental surface (stainless steel) and compared to the U.S. Centers for Disease Control and Prevention 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel (Revision 4, Effective 6/12/2020). RESULTS: Results of the in silico analysis demonstrated the specificity of the method in being able to detect SARS-CoV-2 target sequences and discriminate them from near-neighbors. In the matrix study, the candidate method demonstrated statistically significant better recovery of the target analyte then the reference method (2 x 10(3) GU/2” x 2” test surface). CONCLUSIONS: The COVID-19 Indoor Test by Phylagen is a rapid and accurate method that can be utilized to monitor the presence of SARS-CoV-2, the causative agent of COVID-19, on stainless steel surfaces in built environments. HIGHLIGHTS: The COVID-19 Indoor Test by Phylagen assay performed significantly better than the reference method when used to detect SARS-CoV-2 from environmental surfaces. can signal the need for more effective cleaning and sanitizing measures. The presence of the virus's genetic material on environmental surfaces is most easily, quickly and reliably detected using RT-qPCR, which identifies the novel coronavirus and distinguishes it from other viruses through its unique RNA sequence. This is the same technology used to diagnose patients with COVID-19 based on samples from nasal swabs or saliva. ScholarOne Support phone: 434-964-4100 email: ts.mcsupport@thomson.com The COVID-19 Indoor Test™ by Phylagen is intended to detect SARS-CoV-2 RNA on common surfaces in our everyday environment. Environmental surface swabs are collected by the user and shipped back to Phylagen, Inc. for sample processing and report generation. SARS-CoV-2 RNA is extracted and concentrated from environmental samples and detected through the use of quantitative reverse transcription PCR (RT-qPCR). Sample data are analyzed, and results are reported through our tracking portal. (c) Swabs. (d) Gloves. (e) Box seal. (f) Return shipping label. (g) Instructions. ScholarOne Support phone: 434-964-4100 email: ts.mcsupport@thomson.com (c) Refuse receptacle. All samples should be viewed as potentially containing SARS-CoV-2 virus. Wear appropriate personal protective equipment. The test kit should be kept at room temperature. Confirm that the user has access to internet signal in order to access the Phylagen portal. This is integral to being able to enter necessary metadata for each sample collected. Before sample collection, the user is advised to wash their hands. Prior to collecting samples, the user should register their contact information using the secure Phylagen web portal. The Phylagen portal will act as the primary source of metadata collection during the sampling process. As each sample is collected, important information about the location and surface type of the sample are recorded. This information will follow the sample through collection, laboratory processing and report generation to the customer through the use of the barcode on the side of the tube. When ready to collect samples, sign into the Phylagen portal, review the test plan (if one has been uploaded) and ensure a trash receptacle is nearby for easy disposal of refuse. Open the test kit box, put Holding the sample tube in one hand, insert the swab into the open tube and press the stem at the back of the swab to release the swab head. Using the prompts in the portal follow the directions to record your sample information, along with the barcode. This process will be repeated for each sample. After recording the metadata, the operator will close the tube, making sure that the lid snaps securely. Make sure the tube is closed tightly and return it to its original position in the box Once samples have been accessioned, 2 negative extraction controls (NEC) are prepared for each batch of kits to be processed (one control negative for both the IPC and N1, and one control negative for buffer and ready for analysis using the RT-qPCR assays. ScholarOne Support phone: 434-964-4100 email: ts.mcsupport@thomson.com RT-qPCR is performed in a 384-well PCR format. The 1-Step RT-qPCR mastermix is prepared Positive template controls (PTC) serve as reference dilution series for both assays. IPC and SARS-CoV-2 RNA are diluted independently in 5-fold from 100,000 copies to 6.4 copies. The PTCs dilutions are run in triplicate, for a total of twenty-one PCR controls per assay. In addition to the PTCs, no template controls (NTC) are included in triplicate, for each assay. The plate is sealed with an optical seal and loaded onto an Applied Biosystems QuantStudio thermal cycler. The LIMS integrates with QuantStudio by setting a run plate layout, which assigns sample or control identifiers to be used in run analysis. Following qPCR, qualitative inspection of PTCs, NECs, NTCs, and all N1 positives, is performed to assess the validity of the test batch. Observation of any NEC or NTC replicates crossing the N1 assay threshold results in undetermined calls for all samples on the plate. In this case, these samples will be reprocessed. N1 positives are manually inspected to ensure results fall within accepted quality control metrics established in the product development phase of Phylagen's testing. The QuantStudio instrument software assigns a CT to a sample if the amplification for that sample crosses the set threshold value of 0.05, which was determined through product development. If a sample does not cross the threshold, it is assigned a non-amplification designation. The qPCR output file is uploaded into the LIMS, where the sample results are linked with the sample data previously entered by the kit user, and a report is generated. There are three interpretations of the data, which result in the final calls reported to a customer. ScholarOne Support phone: 434-964-4100 email: ts.mcsupport@thomson.com The assignments are linked to the sample barcodes through LIMS, and a report is accessible on the Phylagen results portal (my.phylagen.com). Table 1 The inclusivity of the COVID-19 Indoor Test by Phylagen primer set (CDC design N1) was evaluated by in silico analysis against a collection of 15,766 SARS-CoV-2 genomes obtained from Global Initiative on Sharing All Influenza Data (GISAID; 3). This genome collection was provided by the AOAC Research Institute and represents genomes collected between December 2019 to June 26th, 2020. The list was filtered to remove duplicates and low-quality sequences defined as >300 Ns. We used thermonucleotideBLAST 4 to evaluate the inclusivity of our primer set against this genome dataset. A total of 15,717 genomes (99.7%) had a perfect match with the forward primer. For the remaining 47 genomes, we detected various mismatches against the forward primer: 2 genomes with a mismatch ScholarOne Support phone: 434-964-4100 email: ts.mcsupport@thomson.com Page 10 of 21 of 7 nucleotides, 8 genomes with a mismatch of 4 nucleotides, 6 genomes with a mismatch of 3 nucleotides, 9 genomes with a mismatch of 2 nucleotides and 24 genomes with a mismatch of 1 nucleotide. A total of 15,678 genomes (99.4%) had a perfect match with the reverse primer. The remaining 86 genomes had different numbers of mismatches against the reverse primer: 5 genomes with a mismatch of 3 nucleotides, 1 genome with a mismatch of 2 nucleotides and 80 genomes with a mismatch of 1 nucleotide. A total of 15,720 genomes (99.7%) had a perfect match when evaluating the N1 probe used in the COVID-19 Indoor Test by Phylagen assay. The remaining 46 genomes (0.3%) had a mismatch of 1 nucleotide when aligned to the probe sequence (24 nucleotides) against the reference genomes. The exclusivity of the genomes was evaluated by searching for the primers on a set of seven viral genomes defined by AOAC ( Table 2) . Both primers (forward and reverse) were searched on these genomes using thermonucleotideBLAST (4). There were no matches between the primers and any of the seven genomes evaluated. Possible background amplification of the primers was evaluated against a dataset of different genomes, including multiple viral, bacterial, fungal and other eukaryotic genomes. The procedure was similar as before, where thermonucleotideBLAST was used to evaluate the match of the primer set against these genomes. ScholarOne Support phone: 434-964-4100 email: ts.mcsupport@thomson.com We used the minimum set of background genomes established by AOAC guidelines (29 Viruses, 21 Bacteria, 2 Fungi, and 8 Eukaryotes), and expanded it to also include all avian influenza genomes available in the National Center for Biotechnology Information (NCBI) database. The viral analysis included 29 viruses established by the AOAC guidelines ( We did not detect any matches against the background fungal or eukaryotic genomes analyzed (Table 5) . ScholarOne Support phone: 434-964-4100 email: ts.mcsupport@thomson.com The prediction was done using the reverse transcription temperature at 55°C, using the previously mentioned salt concentrations. One secondary structure was predicted (Figure 1) , with a ΔG value of -40.09 kcal/mol. The FP region was obtained by making the reverse complement of the target region (from the previous step) and converting all U's to T's. The generated sequence was: TGCTATTGGTGTTAATTGGAACGCCTTGTCCTCGAGGGAATTTAAGGTCTTCCTTGCCATGTTGAGTGAGAGCGGT GAACCAAGACGCAGTATTATTGGGTAAACCTTGGGGCCGACGTTGTTTTGATCGCGCCCCACTGCGTTCTCCATTC TGGTTACTGCCAGTTGAATCTGAGGGTCCACCAAACGTAATGCGGGGTGCATTTCGCTGATTTTGGGGTCCATTAT CAGACATTTTAGTTTGTTCGTTTAGATGAAATCTAAAACAACACGAACGTCATGATACTCTAAAAAGTCTTCATAGA ACGAACAACGCACTACAAGACTACCCAATTTAGGTTCCTGGCAATTAATTGTAAAAGGTAAACAGGA Prediction of the secondary structure was done using the annealing temperature (60°C), with the resulting structure having a ΔG of -1.43 kcal/mol (Figure 2) . Given that the assay probe binds to the sense DNA strand, we selected this strand for the prediction of the secondary structure of the probe binding region. For this, the target region RNA (Step 1) was used, with all U's replaced by T's. The prediction was performed using the extension temperature (60°C), with the resulting structure having a ΔG of -1.49 kcal/mol (Figure 3 ). The secondary structure of the forward and reverse primers, and the probe, were predicted using VisualOMP (Version 7.8.42.0). For all predictions, the annealing temperature was used (60°C), and using the PCR salt concentrations (monovalent ions, 0.08M; Mg2+, 0.002M). ScholarOne Support phone: 434-964-4100 email: ts.mcsupport@thomson.com The predicted structure for the forward primer (Figure 4) , had a ΔG of 2.8 kcal/mol. The structure for the reverse primer ( Figure 5 ) had a ΔG of 0.56 kcal/mol. And the predicted structure of the probe had a ΔG of 1.15 kcal/mol (Figure 6 ). Using Table 6 . Methodology.-The SARS-CoV-2 isolate used for these studies, USA_WA1/2020, was isolated from the first documented US case of a traveler from Wuhan, China (7). SARS-CoV-2 was sourced from the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA). The virus stock was received from WRCEVA as a 1 mL lyophilizate. Upon receipt the lyophilizate was resuspended in 2 mL of PBS and single-use aliquots (50 µL) frozen at -70°C. Instructions for Use and are summarized in Table 8 . The synthetic RNA standard curve consisted of the following concentrations: 1×10 1 , 1×10 2 , 1×10 3 , 1×10 4 and 1×10 5 GC/ L. SARS-CoV-2 virus stock was diluted in nuclease-free water for testing at the following dilutions: 10 -1 , 10 -2 , 10 -3 , 10 -4 , 10 -5 . Master mix was prepared as noted in Table 9 . For the RT-PCR reaction, 15 µL of prepared master mix was added to each well followed by 5 µL of standard or sample, for a final total volume of 20 µL per reaction well. Both RNA standards and SARS-CoV-2 sample dilutions were run in triplicate wells. The GC/mL of the SARS-CoV-2 dilutions was determined using the slope and y-intercept of the synthetic RNA standard curve, as determined by linear regression analysis. The GC/mL of the virus stock was determined based on the average of the triplicate well results for all dilutions within the standard curve range. For the SARS-CoV-2 stock used for these studies, the concentration was calculated to be 1.6 × 10 9 GC/mL. Results.-As per criteria outlined in Appendix J of the Official Methods of Analysis Manual, fractional positive results were obtained for the CDC reference method. The probability of detection (POD) was calculated as the number of positive outcomes divided by the total number of trials. POD was calculated for the candidate presumptive results, POD C and the reference method, POD R as well as the difference in the candidate and reference methods, dPOD C . The POD analysis between the Phylagen COVID-19 Indoor Test and the reference method indicated that there was a significant difference between the two methods, with the candidate method detecting more positive samples than the reference method which is acceptable as described in AOAC Appendix J policies. A summary of POD analyses is presented in Table 15 . Individual results are provided in Table 16 . Results from the POD analysis demonstrated that the COVID-19 Indoor Test by Phylagen was statistically better at detecting low concentrations (2 x 10 3 GU/ 2" x 2" test surface) of deposited SARS-CoV-2 on a stainless steel surface compared to the CDC reference method. In addition, all high concentration samples were all positive and no false negatives were detected with the COVID-19 Indoor Test by Phylagen at either concentration. These data support high analytical sensitivity for SARS-CoV-2. The high sensitivity may be attributed, in part, to viral degradation. Viruses deposited onto surfaces undergo some degradation due to environmental factors, such as heat and humidity. Lysis of viral particles due to degradation could make it more likely that a single target assay would have a higher probability of detecting one target than an assay that requires the detection of both targets to be Assay sensitivity and specificity was further explored and confirmed through in silico analysis for inclusivity and exclusivity against background organisms. It was demonstrated that the COVID-19 Indoor Test by Phylagen can accurately detect 15,745 genomes of the 15,766 that are part of the inclusivity dataset (99.88%) with up to two nucleotide mismatches on the forward and/or reverse primer. While mismatches against these genome sequences could be due to natural variation on the strains, they may be attributed to de novo sequence errors, given the low number of genomes with some mismatches to the primer sequences. Furthermore, none of the exclusivity viral targets were amplified by the primer set, and from the background set only 4 microbial genomes (Table 4 ) showed any possible amplification in silico. These are uncommon microorganisms not expected to be found on indoor surfaces tested for SARS-CoV-2. Additionally, in silico amplification required a large number of mismatches on both primers to proceed. This data suggests the specificity of this primer set for only sequences from SARS-CoV-2. The data from this study supports the product claim that the COVID- Aedes aegypti GCF_002204515 Dermatophagoides pteronyssinus GCF_001901225 Drosophila GCF_000001215 Chlorocebus sabaeus GCA_000409795 United States Center for Disease Control Real Time-PCR Diagnostic Panel for SARS 30494. GISAID: Global initiative on sharing all